Eagle Bluffs Wealth Management’s AbbVie ABBV Stock Holding History

Eagle Bluffs Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$630K	Hold	2,504	–	–	0.21%	58
2026 Q1	$545K	Hold	2,504	–	–	0.21%	60
2025 Q4	$572K	Hold	2,504	–	–	0.23%	58
2025 Q3	$580K	Hold	2,504	–	–	0.25%	56
2025 Q2	$465K	Buy	2,504 +8	+0.3%	+$1.49K	0.22%	61
2025 Q1	$523K	Buy	2,496 +7	+0.3%	+$1.36K	0.28%	56
2024 Q4	$442K	Sell	2,489 -5	-0.2%	-$919	0.24%	57
2024 Q3	$493K	Hold	2,494	–	–	0.27%	55
2024 Q2	$428K	Buy	2,494 +47	+2%	+$7.79K	0.25%	55
2024 Q1	$446K	Hold	2,447	–	–	0.28%	57
2023 Q4	$379K	Hold	2,447	–	–	0.26%	58
2023 Q3	$365K	Hold	2,447	–	–	0.28%	58
2023 Q2	$330K	Hold	2,447	–	–	0.25%	57
2023 Q1	$390K	Buy	2,447 +150	+7%	+$22.9K	0.32%	54
2022 Q4	$371K	Hold	2,297	–	–	0.39%	54
2022 Q3	$308K	Sell	2,297 -109	-5%	-$15.6K	0.36%	55
2022 Q2	$369K	Hold	2,406	–	–	0.4%	55
2022 Q1	$390K	Buy	2,406 +18	+0.8%	+$2.62K	0.38%	56
2021 Q4	$323K	Buy	+2,388	New	+$282K	0.34%	55

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Eagle Bluffs Wealth Management's ABBV Position: Q2 2026 in Review

Eagle Bluffs Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 2,504 shares worth $630K. The position accounts for 0.21% of the portfolio, ranked #58.

Eagle Bluffs Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Eagle Bluffs Wealth Management held 2,504 shares of AbbVie worth $630K as of Q2 2026.
Eagle Bluffs Wealth Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.21% of Eagle Bluffs Wealth Management's portfolio in Q2 2026, its #58 holding.
Eagle Bluffs Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Eagle Bluffs Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.